Mihail Obrocea, Chief Medical Officer at MAIA Biotechnology, Inc. (MAIA), bought 1,000 shares at $5.00 ($5K) on 2022-08-01, disclosed to the SEC on 2022-08-02.
Open-market purchase of $5k MAIA by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.